Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Circio Holding ASA

Market Cap 1.81B 190M 164M 151M 142M 267M 17.96B 269M 1.79B 696M 8.81B 714M 699M 30.49B P/E 2024
0.25x
P/E 2025 -2.65x
Enterprise Value 1.81B 191M 164M 151M 142M 267M 17.98B 269M 1.79B 697M 8.82B 715M 700M 30.53B EV / Sales 2024
-
EV / Sales 2025 -
Free-Float
69.39%
Yield 2024 *
-
Yield 2025 -

Last Transcript: Circio Holding ASA

1 day+3.40%
1 week-8.87%
Current month-15.56%
1 month-31.65%
3 months+33.10%
6 months+538.66%
Current year+552.92%
1 week 7.02
Extreme 7.02
8.29
1 month 7.02
Extreme 7.02
11.56
Current year 0.98
Extreme 0.978
14.46
1 year 0.55
Extreme 0.547
14.46
3 years 0.48
Extreme 0.48
20.4
5 years 0.48
Extreme 0.48
274.5
10 years 0.48
Extreme 0.48
1,017
Manager TitleAgeSince
Chief Executive Officer - 20/10/2021
Director of Finance/CFO 58 07/03/2022
Chief Tech/Sci/R&D Officer - 01/01/2022
Director TitleAgeSince
Director/Board Member 79 01/07/2015
Director/Board Member 66 14/09/2015
Chairman 64 29/04/2020
Date Insider Type Main position Quantity % Market Cap.
30/11/21Fiscal year

Chief Executive Officer

120,000 0.1386%
19/05/21Buy

Director

21,299 0.0246%
03/12/20Buy

Chief Technology Officer

10,000 0.0116%
Change 5-day change 1-year change 3-year change Capi.($)
+3.40%-8.87%+1,069.23%-62.58% 184M
+3.23%+2.93%+61.50%+113.87% 54.54B
+0.04%+5.05%+43.44%+36.75% 43.86B
+3.04%+6.61%-13.27%-18.06% 22.63B
+3.07%-0.60%-3.09%+392.25% 20.7B
-0.53%-0.27%+12.68%-37.07% 15.84B
+5.27%+1.71%+11.09%-38.81% 14.83B
+0.65%-1.04%+25.60%+174.70% 13.1B
-5.17%+4.13%+13.12% - 12.66B
-0.27%+4.82%+75.35%+104.79% 11.56B
Average +1.27%-1.03%+129.57%+73.98% 20.99B
Weighted average by Cap. +1.53%+0.17%+32.54%+90.55%

Financials

2024 2025
Net sales - -
Net income 57.52M 6.05M 5.22M 4.8M 4.52M 8.49M 571M 8.56M 56.86M 22.14M 280M 22.71M 22.22M 969M -45.91M -4.83M -4.17M -3.83M -3.6M -6.77M -456M -6.83M -45.38M -17.67M -224M -18.12M -17.73M -774M
Net Debt -972K -102K -88.19K -81.08K -76.31K -143K -9.65M -145K -961K -374K -4.73M -384K -375K -16.38M 2.24M 236K 204K 187K 176K 331K 22.28M 334K 2.22M 864K 10.94M 886K 867K 37.83M
Logo Circio Holding ASA
Circio Holding ASA, formerly Targovax ASA, is a Norway-based company active within the healthcare sector. The Company is engaged in the biotechnology and develops ribonucleic acid (RNA) and immunotherapy medicines. The Company offers circular RNA (circRNA) platform to develop circRNA medicines for cancer, vaccines, protein replacement for genetic disorders and cell therapy. The circVec technology is based on a modular genetic cassette design for efficient biogenesis of multifunctional circRNA from DNA-based vectors that can be deployed for multiple purposes. Circios strategy is to develop circAde cancer medicines in-house and seek partnerships in other therapeutic areas to demonstrate the broad potential of the circVec platform and accelerate circRNA pipeline development. Circio’s second clinical program is an immunotherapy targeting KRAS driver mutations.
Employees
10
Date Price Change Volume
18/06/26 7.600 kr +3.40% 9,946,023
16/06/26 7.350 kr -9.59% 8,248,773
15/06/26 8.130 kr -0.37% 2,288,009
12/06/26 8.160 kr +9.09% 7,624,359
11/06/26 7.480 kr -6.85% 7,789,340

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TRVX Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!